CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | March/April 2014

An Interview With Marco A. Costa, MD, PhD

An expert in cardiovascular diseases discusses his preferred assessments, treatments, and tools of the trade, as well as tips for medical centers that wish to optimize their resources.

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

Building an Efficient TAVR Program

By Sandeep M. Patel, MD; J. Brandon Elmore, MD; Edwin G. Avery, MD; Marco A. Costa, MD, PhD; Alan Markowitz, MD; Angela Davis, RN; and Guilherme F. Attizzani, MD; on behalf of The Valve Structural Heart Disease Intervention Center, Harrington Heart and Vascular Institute, Cleveland, OH

cit | Article | July/August 2010

High-Resolution Lesion Assessment With OCT

What every interventional cardiologist needs to know about this FDA-approved imaging modality.

By Sahil A. Parikh, MD, and Marco A. Costa, MD, PHD

cit | Article | July/August 2015

Identification of Vulnerable Plaques

Various imaging methods allow evaluation in vivo.

By Daisuke Nakamura, MD; Setsu Nishino, MD, PhD; Guilherme F. Attizzani, MD; Hiram G. Bezerra, MD, PhD; and Marco A. Costa, MD, PhD

Advertisement

Advertisement

cit | Article | November/December 2007

Use of IVUS for Coronary CTO Procedures

An update on the technology and use of IVUS in this challenging coronary niche.

By John E. Coletta, MD; Etsuo Tsuchikane, MD, PhD; Ravi Nair, MD; Daniel I. Simon, MD; and Marco A. Costa, MD, PhD

cit | Article | November/December 2007

Coronary CTOs

By Ted E. Feldman, MD, Chief Medical Editor

cit | Article | March/April 2014

Structural Heart Interventions

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | July/August 2015

Structural Disease Update

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | July/August 2010

Aortic and Mitral Valves

By Ted E. Feldman, MD, FSCAI

cit | News | April 8, 2009

Study Shows Importance of Optimal Stent Deployment

April 9, 2009—Cordis Corporation (Warren, NJ) announced that Marco Costa, MD, presented data showing that optimal deployment of the Cypher sirolimus-eluting coronary stent, especially in patients with diabetes, is important to maximize the therapeutic potential of the device.

cit | Article | July/August 2018

An Interview With Marco Barbanti, MD

Dr. Barbanti discusses the background of the FAST-TAVI study, MitraClip implantation, and addressing CAD in patients undergoing TAVI.

cit | Article | January/February 2012

INNOVATIONS

A preview of today's new products

cit | Article | March/April 2018

Trends in European TAVI Practice

Current application of TAVI in Europe.

By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD

cit | News | May 23, 2011

FDA Approves Abbott's Xience Nano and Boston Scientific's Promus to Treat Small Vessel CAD

May 24, 2011—Abbott Vascular (Santa Clara, CA) announced that it has received US Food and Drug Administration (FDA) approval for the Xience Nano coronary everolimus-eluting stent (EES) system for the treatment of coronary artery disease in vessels as small as 2.25 mm in diameter.

cit | News | October 31, 2011

Abbott Vascular Receives FDA Approval for Xience Prime DES

November 1, 2011—Abbott Vascular (Santa Clara, CA) announced that it has received US Food and Drug Administration (FDA) approval for the next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease.

cit | News | May 4, 2010

FDA Clears LightLab's C7-XR Coronary OCT Imaging System

May 5, 2010—LightLab Imaging Inc. (Westford, MA) announced that it has received clearance from the US Food and Drug Administration (FDA) for the C7-XR optical coherence tomography (OCT) imaging system and the companion C7 Dragonfly imaging catheter.

cit | Article | March/April 2018

Worldwide Trends in TAVR

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

cit | Article | July/August 2019

Contemporary Catheter-Based Structural Heart and Vascular Access Closure Options

By Rahul Sharma, MD, FACP, FACC, FSCAI, and Nicolas M. Van Mieghem, MD, PhD, FACC, FESC

cit | Article | January/February 2013

Potential Use of OCT Imaging in Clinical Practice

From preintervention to postprocedure follow-up, the utility of optical coherence tomography assessment is examined.

By Daniel Chamié,, MD, and Ricardo A. Costa, MD, PhD

cit | Article | March/April 2021

Antithrombotic Therapy After TAVI

Is aspirin enough?

By Antonio Greco, MD, and Davide Capodanno, MD, PhD


1
2
3
4
5
6
7
8
9

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button